Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
04/2004
04/29/2004US20040082802 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds
04/28/2004EP1206448B1 Novel vitamin d analogues
04/22/2004WO2004033420A1 2,2-DI-SUBSTITUTED 1α,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE
04/15/2004US20040072804 Anticancer agents; skin disorders; bone disorders
04/15/2004US20040069523 Use of Vitamin D-Derivatives in the Treatment of Osteoporosis and related bone disorders, as well as novel vitamin D3-Deviratives
04/08/2004US20040068129 Use of 2-methylene-19-nor-20(S)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
04/07/2004CN1144782C Process for separating vitamin D3
04/01/2004WO2003075932A8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
03/2004
03/24/2004EP1200399B1 Vitamin d3 analogs
03/18/2004WO2003087048A3 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds
03/18/2004US20040054204 Forming calcipotriol
03/10/2004EP1395538A1 Vitamin d analogues
03/04/2004US20040043971 Method of treating and preventing hyperparathyroidism with active vitamin D analogs
03/03/2004EP1394144A1 Extraction of vitamin E, phytosterols and squalene from palm oil
03/03/2004CN1140509C Novel vitamin D. analogues
02/2004
02/26/2004US20040038949 Inhibitors of the enzyme CYP24; useful for treating cell-proliferative disorders and for promoting cell differentiation.
02/25/2004CN1477147A Synthesis of oily chemical product with multifunctional group, its product and its application
02/24/2004US6696431 Administering compounds such as 20(s)-1-alpha,25-dihydroxy-2-methylene-26,27-dihomo-19-norvitamin d3, for the prophylaxis of skin disorders such as psoriasis
02/12/2004US20040030167 Vitamins such as (5Z, 7E)-(1R,3R,20S)-3-methyl-9,10-seco-5,7, 10,(19)-cholestatriene-1,3,25-triol, used for prophylaxis and diagnosis of metabolic disorders
02/10/2004US6689766 Also for treating malignant tumors, rheumatoid arthritis, osteoporosis, diabetes mellitus, hypertension, alopecia, acne, psoriasis, dermatitis, hypercalcemia, hypoparathyroidism and metabolic disorder of cartilage.
02/05/2004US20040023934 Method of treating prostatic diseases using active vitamin D analogues
02/04/2004EP0831838B1 Use of vitamin d 4 derivatives for treating skin disorders
02/04/2004CN1473048A 1 alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
02/04/2004CN1137133C Preparation of sterol and dihydro-sterol ester
02/04/2004CN1137076C Process for producing intermediate products for vitamin D synthesis
01/2004
01/29/2004US20040019023 Administering 9,10-secopregna-5,7,10(19),16- tetraene derivative to a patient for treating skin diseases such as psoriasis
01/15/2004US20040009958 Inhibiting hyperproliferation of malignant or neoplastic cells in acute lymphobalstic leukemia, acute myelogenous leukemia, chronic lymphocytic leukemia, chronic myelogenous leukemia and plasma cell dyscrasias.
01/08/2004WO2004002996A1 Ferrocene compound and use thereof
01/07/2004CN1133621C Cyclohexanediole derivatives
12/2003
12/24/2003WO2003106629A2 Treating vitamin d responsive diseases
12/24/2003WO2003106412A1 Epimerization of analogs of vitamin d
12/24/2003WO2003106411A1 24-sulfoximine vitamin d3 compounds
12/24/2003CN1131871C Prepn. of sterol ester and steriod esters
12/23/2003US6667298 26,27-Homologated-20-EPI-2-alkyl-19-NOR-vitamin D compounds
12/17/2003EP1097132B1 Functional vitamin d derivatives and a method for determining 25-hydroxy-vitamin d and 1alpha,25-dihydroxy-vitamin d
12/10/2003EP1047671B1 Method of preparation of cholecalciferol derivatives and new intermediate compounds
12/09/2003CA2150233C Process for producing provitamin d compound
12/09/2003CA2140247C Novel vitamin d analogues
12/03/2003CN1459446A Method of preparing cis-vitamin D or its derivative by solid phase photosensitizer sensitization using silica gel as carrier
12/03/2003CN1129577C 维生素d3衍生物 Derivatives of vitamin d3
11/2003
11/19/2003EP1362848A1 Process for the preparation of vitamin D derivatives
11/19/2003EP1235832B1 Vitamin d prescursors, method and intermediates
11/12/2003CN1455672A Use of 2-methylene-19-Nor-20(s)-1 alpha, 25-dihydroxy vitamin D3 to increase bone strength
11/11/2003US6646143 Anticancer agents; skin disorders
11/05/2003EP1178960B1 Vitamin d analogues and their pharmaceutical use
11/05/2003EP1082298B1 1-alpha-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
11/04/2003US6642218 (5Z,7E,22E)-(1S,3R,24R)-25-(5-Propyloxazol-2-yl)-26,27-cyclo -9,10-secocholesta-5,7,10(19), 22-tetraene-1,3,24-triol for treatment of diseases characterized by hyperproliferation and deficient cell differentiation
10/2003
10/30/2003WO2003088976A1 Method for treating and preventing hyperparathyroidism
10/30/2003US20030204103 2-Methylene-19-nor-20(S)-1alpha-hydroxy-bis-homo-pregnacalciferol in crystalline form
10/30/2003CA2481120A1 Method for treating and preventing hyperparathyroidism
10/29/2003EP0971888B1 2-alkyl-19-nor-vitamin d compounds
10/29/2003CN1451655A Method for sensitized preparation of cis-vitamin D or its derivs. using cross-linked polymer photosensitizer
10/29/2003CN1451654A Method for photosensitized isomerization of tachysterol and its derivs. into previtamin D and its derivs. using cross-linked polymer photosensitier
10/23/2003WO2003087048A2 Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds
10/23/2003CA2481909A1 Preparation of 24-alkyl analogs of cholecalciferol
10/16/2003WO2003084925A1 METHOD OF SYNTHESIZING 1α-HYDROXY-2-METHYLENE-19-NOR-HOMOPREGNACALCIFEROL
10/16/2003US20030195176 Vitamin d derivatives
10/09/2003US20030191095 Method of synthesizing 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol
10/02/2003US20030187287 Synthesis intermediate products for producing vitamin d derivatives
10/01/2003EP0998455B1 Dihomo-seco-cholestanes with two unsaturated bonds in the side chain
10/01/2003CN1445215A Photochemical method for synthesizing vitamine D3
09/2003
09/25/2003US20030181427 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
09/24/2003EP1080055B1 24-hydroxyvitamin d, analogs and uses thereof
09/18/2003WO2003075932A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/18/2003CA2474771A1 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
09/12/2003WO2003074480A1 Halovinylidenemethylenecyclcohexane compound, borovinylidenemethylenecyclohexane compound, and process for producing vitamine d derivative from the compounds
09/12/2003WO2003051828A3 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
09/11/2003US20030171605 Reduced hypercalcemic activity and enhanced stability in vivo; used as substitutes for natural and synthetic vitamin D3 compounds.
09/11/2003US20030171342 Novel 16-ene-C25-oxime and 16-ene- C-25-oxime ether analogs of 1 alpha ,25-dihydroxy vitamin D3, compositions comprising these compounds and methods of using these compounds as inhibitors of CYP24.
09/04/2003US20030166622 Vitamin D derivatives with acyloxy groups in the side chains, process for their production, and the use for the production of pharmaceutical agents
09/03/2003EP0947504B1 16-ene-vitamin d derivatives
09/02/2003US6613920 25-(5-propylimidazol-2-yl)-26,27-cyclo-9, 10-secocholesta-5,7,10(19),22-tetraene-1,3,24-triol; antagonizes the action of calcitriol in HL 60 cells; hyperprolifierative diseases of the skin, tumor diseases and precancerous stages
08/2003
08/28/2003WO2003070697A1 Method of assaying activity of binding to vitamin d3 receptor using fluorescence polarization
08/27/2003EP1173463B1 Process for the purification of sterols from hydrocarbon extracts using evaporative fractionation
08/27/2003CN1439018A 9alpha-chloro-6alpha-fluoro-17alpha-hydroxy-16-methyl-17-beta-methoxy carbonyl-androst-1, 4-dienes esterified in position 17 alpha by a cyclic acyl group
08/21/2003US20030158163 Conversion of carboxylic acid substituent in a gonane ring, into the methyl ester, or hydrochlorination of a 9-11-epoxy-9-H-cyclopenta(a)phenanthrene compounds
08/13/2003CN1436170A Vitamin D derivs.
08/07/2003US20030149006 New vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/07/2003US20030149005 For therapy and prophylaxis of cancer, dermatological disorders, bone disorders, thyroid disorders, wound healing and osteoporosis
08/05/2003US6603031 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
08/05/2003US6603030 Process for producing phosphineoxide vitamin D precursors
07/2003
07/31/2003WO2003018545B1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
07/30/2003EP1180035A4 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1$g(a), 25-DIHYDROXY VITAMIN D 3?
07/30/2003EP1091936B1 Method for making hydroxy-25-ene-vitamin d compounds
07/29/2003US6600058 Vitamin D derivatives with carbo- or heterocyclic substituents at C-25, a process for their production, intermediate products and their use for producing medicaments
07/23/2003CN1431941A 挤压模 Extrusion die
07/10/2003WO2003055854A1 2-substituted vitamin d derivatives
07/10/2003CA2503801A1 2-substituted vitamin d derivatives
07/03/2003US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof
06/2003
06/26/2003WO2003051828A2 (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
06/25/2003EP1321141A1 Parathyroid hormone production inhibitors containing vitamin d3 derivatives
06/19/2003US20030113361 Palatable arginine compounds and uses thereof for cardiovascular health
06/18/2003CN1425019A Vitamin D Precursors, preparation and intermediates thereof
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/12/2003US20030109506 Treating vitamin D responsive diseases
06/04/2003EP1315504A1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications
06/04/2003CN1110477C 1,25-dihydroxy-16,22,23-trisdehydro-chdecalciferol derivatives
06/03/2003US6573255 Vitamin D analogues
05/2003
05/28/2003EP0874814B1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols
05/22/2003WO2003042171A1 Vitamin d derivatives with acyloxy groups at the 24-position of the side chain, a method for producing the same and use thereof in production of medicaments
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 35